Sun Pharma unveils CEQUA in the US to treat dry eye disease patients

Leading specialty generic pharmaceutical company Sun Pharmaceutical Industries Ltd has reportedly announced the launch of CEQUA (cyclosporine ophthalmic solution) 0.09% in the US by one of its subsidiaries. The drug will evidently be used ....

Topcon partners with IBM for Merge Eye Station and Eye Care PACS users

Ophthalmic device usage and production are projected to witness an exponential growth in the near future due to the growing prevalence of eye conditions. Various pharmaceutical firms across the world are increasingly turning towards the usa....

Gilead, Galapagos reveal FINCH 1 & FINCH 3 trial results of Filgotinib

Autoimmune diseases are on a rise in today’s fast-paced world. Rheumatoid arthritis (RA) is one such clinical condition in which a patient’s immune system attacks its own tissue, including joints. In many cases, the disease....

US senator pleas investigation over TikTok’s Musical.ly acquisition

Musical.ly is a social media service which was released in 2014 in Shanghai and is incorporated in Santa Monica, California. The service was acquired by ByteDance and has been operating as TikTok for overseas markets. However, the viral so....

Midatech initiates Phase 1 trial of a new hormonal cancer therapy

Cancer treatment is one of the biggest challenges for the 21st century. There have been many advancements in the field of cancer treatment over the past few years. Clinical trial indeed plays a pivotal role in discovering new drugs, especia....

Yumanity starts Phase 1 trial of YTX-7739 to treat Parkinson’s disease

Number of cases where people are affected with neurodegenerative diseases have been growing at a substantial pace. Alzheimer’s disease and Parkinson’s disease are the most common neurodegenerative diseases found across the world....

DISH Network inks Multi-Year Carriage Agreement with Fox Corp.

Sports channels are one of the few types of TV broadcasts that people prefer live. No channel is more vital to sports fans than a regional sports network that views their favorite teams. However, a dispute emerged recently between Dish Netw....

Zydus reveals positive data from EVIDENCES IV phase 2 clinical trial

Non-alcoholic Steatohepatitis (NASH) is a progressive disease which can ultimately lead to cirrhosis and liver failure. Liver transplantation is the only treatment for managing advanced cirrhosis with liver failure. There are currently no U....

AngioDynamics buys Eximo Medical and its 355nm Laser Atherectomy tech

Owing to widescale tobacco use, the world is seeing an increased number of cancer and vascular diseases. India alone registers more than 10 million cases of peripheral artery disease on an annual basis. Technology and healthcare enterprises....

Scholar Rock to showcase preclinical, phase 1 clinical data of SRK-015

SMA is a rare genetic disease that typically affects young children. Currently, there is no cure for spinal muscular atrophy (SMA), however, various pharmaceutical firms across the world are working to discover a novel, innovative treatment....